Shuttle Pharma signs $10M term sheet to buy Molecule assets; CRO Theradex terminates, seeks $1.09M

Shuttle Pharmaceuticals Holdings, Inc.

Binding term sheet for $10M purchase of substantially all assets and liabilities of Molecule; consideration in cash and stock per Shuttle's sole discretion, with milestones.
CRO Theradex terminated Master Agreement on Oct 15, 2025, demanding immediate payment of $1.091M; if unpaid in 30 days, services will cease.
Theradex is Shuttle's primary CRO; termination threatens clinical trial operations and requires immediate cash payment.
Transaction subject to due diligence, board approval, definitive agreements; exclusivity period of 90 days from Oct 20, 2025.
Shuttle intends to retain Molecule's CEO ZT Zhang for post-transaction transition and integration.

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001493152-25-018788
form_type: 8-K
ticker: SHPH
cik: 0001757499
company_name: Shuttle Pharmaceuticals Holdings, Inc.
filed_at: 2025-10-21T23:59:59+00:00
discovered_at: 2026-05-14T18:02:40.348693+00:00
generated_at: 2026-05-17T03:03:56.298456+00:00
sec_items: ["1.01", "1.02", "9.01"]
event_type: other_material
sentiment: negative
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001493152-25-018788
json_url: https://secwatch.observer/filing/0001493152-25-018788.json
markdown_url: https://secwatch.observer/filing/0001493152-25-018788.md
text_url: https://secwatch.observer/filing/0001493152-25-018788.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1757499/000149315225018788/0001493152-25-018788-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1757499/000149315225018788/form8-k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

zSpace restructures $12M debt via equity conversion; creates Series P-2 preferred

zSpace, Inc. June 1, 2026, 8:00 AM ET other_material Items 1.01, 1.02, 2.03, 3.02, 5.03, 9.01

same SEC item: 1.01, 1.02, 9.01 same event type: other_material similar materiality

Disciplined Growth Acquisition Corp. closes $150M IPO on NYSE

DISCIPLINED GROWTH ACQUISITION Corp June 1, 2026, 4:15 PM ET other_material Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01

same SEC item: 1.01, 9.01 same event type: other_material similar materiality

Optimum raises $500M via preferred units, starts $300M tender at $2.50 to shield assets from CSC debt

Optimum Communications, Inc. June 1, 2026, 8:16 AM ET other_material Items 1.01, 3.02, 7.01, 8.01, 9.01

same SEC item: 1.01, 9.01 same event type: other_material similar materiality

AII

American Integrity fully places 2026-2027 CAT XOL reinsurance with $2.99B total limit

American Integrity Insurance Group, Inc. June 1, 2026, 4:31 PM ET other_material Items 7.01, 9.01